Renal Denervation Market Size, Share & Trends Analysis Report By Technology (Micro-Infusion, Ultrasound, Radiofrequency Based), By Region (Europe, APAC, MEA, North America), And Segment Forecasts, 2018 - 2026
This report can be delivered to the clients within 72 Business Hours
The global renal denervation market size is expected to reach USD 1.03 billion by 2026, according to a new report by the Grand View Research, Inc. The market is estimated to register a CAGR of 43.2% during the forecast period. Growing incidences of hypertension, changing lifestyle, and enduring effect of renal denervation procedure are the key factors driving market.
Increasing cases of uncontrolled and drug-resistant hypertension are expected to fuel the demand for renal denervation. As per the data published in November 2016, by the Centre for Disease Control and Prevention (CDC), about 75 million people in U.S. have high blood pressure. High blood pressure increases the risk of stroke and heart disease, a leading cause of deaths in America. Complications of hypertension causes 9.4 million deaths each year. Furthermore, hypertension is responsible for at least 51% of deaths due to stroke and 45% of deaths due to heart disease.
The renal denervation market in developed economies, such as U.K., France, and Italy, is comparatively mature owing to the presence of key companies in these countries and high demand for such products. Europe commanded the largest share owing to the rise in number of drug-resistant hypertension cases and technological advancements.
On the other hand, developing countries of Asia and Latin America are expected to witness the fastest growth due to economic growth and increased consumer disposable income. Further, growing elderly population coupled with high prevalence of diabetes in these region sis anticipated to propel the region’s development.
Further key findings from the report suggest:
The global renal denervation market size is expected to reach USD 1.03 billion by 2026, according to a new report by the Grand View Research, Inc. The market is estimated to register a CAGR of 43.2% during the forecast period. Growing incidences of hypertension, changing lifestyle, and enduring effect of renal denervation procedure are the key factors driving market.
Increasing cases of uncontrolled and drug-resistant hypertension are expected to fuel the demand for renal denervation. As per the data published in November 2016, by the Centre for Disease Control and Prevention (CDC), about 75 million people in U.S. have high blood pressure. High blood pressure increases the risk of stroke and heart disease, a leading cause of deaths in America. Complications of hypertension causes 9.4 million deaths each year. Furthermore, hypertension is responsible for at least 51% of deaths due to stroke and 45% of deaths due to heart disease.
The renal denervation market in developed economies, such as U.K., France, and Italy, is comparatively mature owing to the presence of key companies in these countries and high demand for such products. Europe commanded the largest share owing to the rise in number of drug-resistant hypertension cases and technological advancements.
On the other hand, developing countries of Asia and Latin America are expected to witness the fastest growth due to economic growth and increased consumer disposable income. Further, growing elderly population coupled with high prevalence of diabetes in these region sis anticipated to propel the region’s development.
Further key findings from the report suggest:
- Ultrasound based renal denervation segment is projected to register a remarkable CAGR of 43.5% over the forecast period as it overcomes the limitation of radiofrequency devices
- Europe led the renal denervation market in 2017 due to high number of drug-resistant hypertension cases and initiatives, such as R&D, for the development of effective devices
- Asian countries are estimated to witness the highest growth over the forecast period, due to increasing target population coupled with rising prevalence of diabetes
- Developing countries of China and India are the major drivers of the regional market due to populations
- Key companies in the market are Medtronic PLC; Cardiosonic, Inc.; Kona Medical, Inc.; Abbott Laboratories; Ablative Solutions, Inc.; Renal Dynamics; Mercator MedSystems, Inc.; ReCor Medical, Inc.; Boston Scientific Corp.; and Symple Surgical, Inc.
CHAPTER 1 REPORT SCOPE
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
CHAPTER 2 METHODOLOGY
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity flow analysis (Model 1)
2.6.2 Volume price analysis (model 2)
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 List of Abbreviations
CHAPTER 3 OBJECTIVES
3.1 Objective - 1: Understanding the market dynamics
3.2 Objective - 2: Understanding the market estimates and forecasts
3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization
3.4 Objective - 4: Understanding the key end-users, technological, application and product scopes
CHAPTER 4 EXECUTIVE SUMMARY
CHAPTER 5 MARKET DEFINITION
CHAPTER 6 INDUSTRY OUTLOOK
6.1 Market Segmentation
6.2 Business Segment Trends
6.2.1 Product business analysis
6.2.2 Regional business analysis
6.3 Market Variable Analysis
6.3.1 Market driver analysis
6.3.1.1 Growing prevalence of hypertension
6.3.1.2 Changing lifestyle of people
6.3.1.3 Enduring effect of the procedure
6.3.2 Market restraint analysis
6.3.2.1 Painful procedure
6.4 Penetration & Growth Prospect Mapping
6.5 Business Environment Analysis tools
6.5.1 SWOT Analysis, by PEST
6.5.1.1 Political & Legal
6.5.1.2 Economic
6.5.1.3 Technological
6.5.2 Porter’s five forces analysis
6.5.2.1 Bargaining power of buyers: Low
6.5.2.2 Bargaining power of suppliers: High
6.5.2.3 Competitive rivalry: High
6.5.2.4 Threat of new entrants: Moderate
6.5.2.5 Threat of substitutes: Low
6.5.3 Industry Analysis - Ansoff’s Matrix
CHAPTER 7 RENAL DENEVATION MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
7.1 Renal Denervation Market: Product Movement Analysis
7.2 Radiofrequency Based Renal Denervation
7.2.1 Radiofrequency based renal denervation market, 2014 - 2026 (USD Million)
7.3 Ultrasound Based Renal Denervation
7.3.1 Ultrasound based renal denervation market, 2014 - 2026 (USD Million)
7.4 Micro-Infusion Based Renal Denervation
7.4.1 Micro-Infusion based renal denervation market, 2014 - 2026 (USD Million)
CHAPTER 8 RENAL DENEVATION MARKET: REGION ESTIMATES & TREND ANALYSIS, BY TECHNOLOGY
8.1 Renal Denervation Market: Region Movement Analysis
8.2 North America
8.2.1 North America renal denervation market, by technology, 2014 - 2026 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. renal denervation market, by technology, 2014 - 2026 (USD Million)
8.2.3 Canada
8.2.3.1 Canada renal denervation market, by technology, 2014 - 2026 (USD Million)
8.3 Europe
8.3.1 Europe renal denervation market, by technology, 2014 - 2026 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. renal denervation market, by technology,2014 - 2026 (USD Million)
8.3.3 Germany
8.3.3.1 Germany renal denervation market, by technology, 2014 - 2026 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific renal denervation market, by technology, 2014 - 2026 (USD Million)
8.4.2 Japan
8.4.2.1 Japan renal denervation market, by technology, 2014 - 2026 (USD Million)
8.4.3 China
8.4.3.2 China renal denervation market, by technology, 2014 - 2026 (USD Million)
8.5 Latin America
8.5.1 Latin America renal denervation market, by technology, 2014 - 2026 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil renal denervation market, by technology, 2014 - 2026 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico renal denervation market, by technology, 2014 - 2026 (USD Million)
8.6 MEA
8.6.1 MEA renal denervation market, by technology, 2014 - 2026 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa renal denervation market, by technology, 2014 - 2026 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia renal denervation market, by technology, 2014 - 2026 (USD Million)
CHAPTER 9 COMPANY PROFILES
9.1 Strategic Framework
9.2 Company Profiles
9.2.1 Medtronic
9.2.1.1 Company overview
9.2.1.2 Financial performance
9.2.1.3 Product benchmarking
9.2.1.4 Strategic initiatives
9.2.2 Kona Medical
9.2.2.1 Company overview
9.2.2.2 Financial performance
9.2.2.3 Product benchmarking
9.2.2.4 Strategic initiatives
9.2.3 Abbott
9.2.3.1 Company overview
9.2.3.2 Financial performance
9.2.3.3 Service benchmarking
9.2.3.4 Strategic initiatives
9.2.4 CardioSonic
9.2.4.1 Company overview
9.2.4.2 Product benchmarking
9.2.4.3 Strategic initiatives
9.2.5 Renal Dynamics
9.2.5.1 Company overview
9.2.5.2 Product benchmarking
9.2.5.3 Strategic initiatives
9.2.6 ReCor Medical
9.2.6.1 Company overview
9.2.6.2 Financial performance
9.2.6.3 Product benchmarking
9.2.6.4 Strategic initiatives
9.2.7 Boston Scientific Group
9.2.7.1 Company overview
9.2.7.2 Financial performance
9.2.7.3 Product benchmarking
9.2.7.4 Strategic initiatives
9.2.8 Symple Surgical
9.2.8.1 Company overview
9.2.8.2 Product benchmarking
9.2.9 Ablative Solutions
9.2.9.1 Company overview
9.2.9.2 Financial performance
9.2.9.3 Product benchmarking
9.2.9.4 Strategic initiatives
9.2.10 Mercator MedSystems
9.2.10.1 Company overview
9.2.10.2 Financial performance
9.2.10.3 Product benchmarking
9.2.10.4 Strategic initiatives
CHAPTER 10 KOL COMMENTARY
10.1 Key Insights
10.2 KOL Views
CHAPTER 11 RECOMMENDATIONS
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
CHAPTER 2 METHODOLOGY
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity flow analysis (Model 1)
2.6.2 Volume price analysis (model 2)
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 List of Abbreviations
CHAPTER 3 OBJECTIVES
3.1 Objective - 1: Understanding the market dynamics
3.2 Objective - 2: Understanding the market estimates and forecasts
3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization
3.4 Objective - 4: Understanding the key end-users, technological, application and product scopes
CHAPTER 4 EXECUTIVE SUMMARY
CHAPTER 5 MARKET DEFINITION
CHAPTER 6 INDUSTRY OUTLOOK
6.1 Market Segmentation
6.2 Business Segment Trends
6.2.1 Product business analysis
6.2.2 Regional business analysis
6.3 Market Variable Analysis
6.3.1 Market driver analysis
6.3.1.1 Growing prevalence of hypertension
6.3.1.2 Changing lifestyle of people
6.3.1.3 Enduring effect of the procedure
6.3.2 Market restraint analysis
6.3.2.1 Painful procedure
6.4 Penetration & Growth Prospect Mapping
6.5 Business Environment Analysis tools
6.5.1 SWOT Analysis, by PEST
6.5.1.1 Political & Legal
6.5.1.2 Economic
6.5.1.3 Technological
6.5.2 Porter’s five forces analysis
6.5.2.1 Bargaining power of buyers: Low
6.5.2.2 Bargaining power of suppliers: High
6.5.2.3 Competitive rivalry: High
6.5.2.4 Threat of new entrants: Moderate
6.5.2.5 Threat of substitutes: Low
6.5.3 Industry Analysis - Ansoff’s Matrix
CHAPTER 7 RENAL DENEVATION MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
7.1 Renal Denervation Market: Product Movement Analysis
7.2 Radiofrequency Based Renal Denervation
7.2.1 Radiofrequency based renal denervation market, 2014 - 2026 (USD Million)
7.3 Ultrasound Based Renal Denervation
7.3.1 Ultrasound based renal denervation market, 2014 - 2026 (USD Million)
7.4 Micro-Infusion Based Renal Denervation
7.4.1 Micro-Infusion based renal denervation market, 2014 - 2026 (USD Million)
CHAPTER 8 RENAL DENEVATION MARKET: REGION ESTIMATES & TREND ANALYSIS, BY TECHNOLOGY
8.1 Renal Denervation Market: Region Movement Analysis
8.2 North America
8.2.1 North America renal denervation market, by technology, 2014 - 2026 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. renal denervation market, by technology, 2014 - 2026 (USD Million)
8.2.3 Canada
8.2.3.1 Canada renal denervation market, by technology, 2014 - 2026 (USD Million)
8.3 Europe
8.3.1 Europe renal denervation market, by technology, 2014 - 2026 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. renal denervation market, by technology,2014 - 2026 (USD Million)
8.3.3 Germany
8.3.3.1 Germany renal denervation market, by technology, 2014 - 2026 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific renal denervation market, by technology, 2014 - 2026 (USD Million)
8.4.2 Japan
8.4.2.1 Japan renal denervation market, by technology, 2014 - 2026 (USD Million)
8.4.3 China
8.4.3.2 China renal denervation market, by technology, 2014 - 2026 (USD Million)
8.5 Latin America
8.5.1 Latin America renal denervation market, by technology, 2014 - 2026 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil renal denervation market, by technology, 2014 - 2026 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico renal denervation market, by technology, 2014 - 2026 (USD Million)
8.6 MEA
8.6.1 MEA renal denervation market, by technology, 2014 - 2026 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa renal denervation market, by technology, 2014 - 2026 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia renal denervation market, by technology, 2014 - 2026 (USD Million)
CHAPTER 9 COMPANY PROFILES
9.1 Strategic Framework
9.2 Company Profiles
9.2.1 Medtronic
9.2.1.1 Company overview
9.2.1.2 Financial performance
9.2.1.3 Product benchmarking
9.2.1.4 Strategic initiatives
9.2.2 Kona Medical
9.2.2.1 Company overview
9.2.2.2 Financial performance
9.2.2.3 Product benchmarking
9.2.2.4 Strategic initiatives
9.2.3 Abbott
9.2.3.1 Company overview
9.2.3.2 Financial performance
9.2.3.3 Service benchmarking
9.2.3.4 Strategic initiatives
9.2.4 CardioSonic
9.2.4.1 Company overview
9.2.4.2 Product benchmarking
9.2.4.3 Strategic initiatives
9.2.5 Renal Dynamics
9.2.5.1 Company overview
9.2.5.2 Product benchmarking
9.2.5.3 Strategic initiatives
9.2.6 ReCor Medical
9.2.6.1 Company overview
9.2.6.2 Financial performance
9.2.6.3 Product benchmarking
9.2.6.4 Strategic initiatives
9.2.7 Boston Scientific Group
9.2.7.1 Company overview
9.2.7.2 Financial performance
9.2.7.3 Product benchmarking
9.2.7.4 Strategic initiatives
9.2.8 Symple Surgical
9.2.8.1 Company overview
9.2.8.2 Product benchmarking
9.2.9 Ablative Solutions
9.2.9.1 Company overview
9.2.9.2 Financial performance
9.2.9.3 Product benchmarking
9.2.9.4 Strategic initiatives
9.2.10 Mercator MedSystems
9.2.10.1 Company overview
9.2.10.2 Financial performance
9.2.10.3 Product benchmarking
9.2.10.4 Strategic initiatives
CHAPTER 10 KOL COMMENTARY
10.1 Key Insights
10.2 KOL Views
CHAPTER 11 RECOMMENDATIONS
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 Leading market players anticipated to witness highest growth
Table 4 Global Renal Denervation Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million)
Table 5 Global Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 6 North America Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 7 North America Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 8 U.S. Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 9 Canada Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 10 Europe Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 11 Europe Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 12 U.K. Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 13 Germany Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 14 Asia Pacific Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 15 Asia Pacific Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 16 China Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 17 Japan Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 18 Latin America Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 19 Latin America Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 20 Brazil Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 21 Mexico Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 22 MEA Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 23 MEA Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 24 South Africa Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 25 Saudi Arabia Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 Leading market players anticipated to witness highest growth
Table 4 Global Renal Denervation Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million)
Table 5 Global Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 6 North America Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 7 North America Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 8 U.S. Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 9 Canada Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 10 Europe Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 11 Europe Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 12 U.K. Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 13 Germany Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 14 Asia Pacific Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 15 Asia Pacific Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 16 China Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 17 Japan Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 18 Latin America Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 19 Latin America Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 20 Brazil Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 21 Mexico Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 22 MEA Renal Denervation Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 23 MEA Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 24 South Africa Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
Table 25 Saudi Arabia Renal Denervation Market Estimates & Forecasts, by Technology, 2014 - 2026 (USD Million)
LIST OF FIGURES
Fig.1 Market research process
Fig.2 Information procurement
Fig.3 Primary research pattern
Fig.4 Market research approaches
Fig.5 Value chain based sizing & forecasting
Fig.6 QFD modelling for market share assessment
Fig.7 Market formulation & validation
Fig.8 Renal denervation market segmentation
Fig.9 Market driver relevance analysis (Current & future impact)
Fig.10 Market restraint relevance analysis (Current & future impact)
Fig.11 SWOT analysis, by factor (political & legal, economic and technological)
Fig.12 Porter’s five forces analysis
Fig.13 Ansoff’s matrix analysis
Fig.14 Renal denervation market product outlook: Key takeaways
Fig.15 Renal denervation market: Product movement analysis
Fig.16 Radiofrequency based renal denervation market, 2014 - 2026 (USD Million)
Fig.17 Ultrasound based renal denervation market, 2014 - 2026 (USD Million)
Fig.18 Micro-infusion based renal denervation market, 2014 - 2026 (USD Million)
Fig.19 Regional market place: Key takeaways
Fig.20 Renal denervation market: Region movement analysis
Fig.21 North America renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.22 U.S. renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.23 Canada renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.24 Europe renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.25 U.K. renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.26 Germany renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.27 Asia Pacific renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.28 Japan renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.29 China renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.30 Latin America renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.31 Brazil renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.32 Mexico renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.33 MEA renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.34 South Africa renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.35 Saudi Arabia renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.1 Market research process
Fig.2 Information procurement
Fig.3 Primary research pattern
Fig.4 Market research approaches
Fig.5 Value chain based sizing & forecasting
Fig.6 QFD modelling for market share assessment
Fig.7 Market formulation & validation
Fig.8 Renal denervation market segmentation
Fig.9 Market driver relevance analysis (Current & future impact)
Fig.10 Market restraint relevance analysis (Current & future impact)
Fig.11 SWOT analysis, by factor (political & legal, economic and technological)
Fig.12 Porter’s five forces analysis
Fig.13 Ansoff’s matrix analysis
Fig.14 Renal denervation market product outlook: Key takeaways
Fig.15 Renal denervation market: Product movement analysis
Fig.16 Radiofrequency based renal denervation market, 2014 - 2026 (USD Million)
Fig.17 Ultrasound based renal denervation market, 2014 - 2026 (USD Million)
Fig.18 Micro-infusion based renal denervation market, 2014 - 2026 (USD Million)
Fig.19 Regional market place: Key takeaways
Fig.20 Renal denervation market: Region movement analysis
Fig.21 North America renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.22 U.S. renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.23 Canada renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.24 Europe renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.25 U.K. renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.26 Germany renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.27 Asia Pacific renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.28 Japan renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.29 China renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.30 Latin America renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.31 Brazil renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.32 Mexico renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.33 MEA renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.34 South Africa renal denervation market, by technology, 2014 - 2026 (USD Million)
Fig.35 Saudi Arabia renal denervation market, by technology, 2014 - 2026 (USD Million)
